Development of the therapeutic regimen based on the synergistic activity of cyclophosphamide and double-stranded DNA preparation which results in complete cure of mice engrafted with Krebs-2 ascites

Cumulative evidence obtained in this series of studies has guided the logic behind the development of a novel composite dsDNA-based preparation whose therapeutic application according to the specific regimen completely cures the mice engrafted with otherwise lethal Krebs-2 ascites. The likely mechan...

ver descrição completa

Detalhes bibliográficos

Principais autores:	E. A. Potter, E. V. Dolgova, A. S. Proskurina, Ya. R. Efremov, O. S. Taranov, V. P. Nikolin, N. A. Popova, T. D. Dubatolova, D. D. Petrova, E. I. Vereschagin, A. M. Minkevich, O. M. Andrushkevich, S. I. Baiborodin, V. A. Rogachev, A. A. Ostanin, E. R. Chernykh, N. A. Kolchanov, S. S. Bogachev
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Siberian Branch of the Russian Academy of Sciences, Federal Research Center Institute of Cytology and Genetics, The Vavilov Society of Geneticists and Breeders 2016-12-01
Colecção:	Вавиловский журнал генетики и селекции
Assuntos:	double-stranded dna cyclophosphamide krebs-2 ascites tumor-initiating stem cells repair remission ner homologous recombination systemic inflammatory reaction multiple organ failure
Acesso em linha:	https://vavilov.elpub.ru/jour/article/view/821
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!